Literature DB >> 8251318

Risks of peritoneal membrane failure in children undergoing long-term peritoneal dialysis.

S P Andreoli1, C D Langefeld, S Stadler, P Smith, A Sears, K West.   

Abstract

Children undergoing long-term peritoneal dialysis are at risk for membrane injury, necessitating conversion to hemodialysis. We analyzed the incidence and risk factors for membrane failure (inadequate ultrafiltration with or without peritoneal adhesions and decreased peritoneal surface area) in 68 children maintained with peritoneal dialysis for more than 3 months at our institution. The overall incidence of membrane failure was 16.2% (11/68). Kaplan-Meier estimates of peritoneal membrane survival were 88% at 24 months, 72% at 36 months, 65% at 48 months, and 52% at 60 months. Logistic regression analysis demonstrated that the risk of membrane failure increased with the number of episodes of peritonitis (odds ratio 1.61). The rate of peritonitis was 1 per 7.02 patient months in children who developed membrane failure compared with 1 per 9.18 patient months in children without membrane failures but the rate of peritonitis was not predictive of membrane failure (P = 0.09). Multiple logistic regression analysis demonstrated that peritonitis caused by Pseudomonas aeruginosa or alpha streptococcal organisms were independent predictors of membrane failure. We conclude that peritoneal membrane survival declines substantially with time on peritoneal dialysis and that membrane failure is associated with peritonitis, particularly peritonitis caused by Pseudomonas aeruginosa and alpha streptococcal organisms. The mechanism(s) of membrane injury are unknown but may be related to the inflammatory response initiated during peritonitis.

Entities:  

Mesh:

Year:  1993        PMID: 8251318     DOI: 10.1007/bf00852541

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  25 in total

Review 1.  Physiology of the peritoneum. Implications for peritoneal dialysis.

Authors:  J F Maher
Journal:  Med Clin North Am       Date:  1990-07       Impact factor: 5.456

2.  Ultrafiltration failure in continuous ambulatory peritoneal dialysis due to excessive peritoneal cavity lymphatic absorption.

Authors:  R A Mactier; R Khanna; Z J Twardowski; K D Nolph
Journal:  Am J Kidney Dis       Date:  1987-12       Impact factor: 8.860

3.  Follow-up of peritoneal clearances in patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  J Rubin; K Nolph; D Arfania; P Brown; B Prowant
Journal:  Kidney Int       Date:  1979-11       Impact factor: 10.612

4.  Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis.

Authors:  C Verger; O Brunschvicg; Y Le Charpentier; A Lavergne; J Vantelon
Journal:  Proc Eur Dial Transplant Assoc       Date:  1981

5.  Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis.

Authors:  N Di Paolo; G Sacchi; M De Mia; E Gaggiotti; L Capotondo; P Rossi; M Bernini; A M Pucci; L Ibba; P Sabatelli
Journal:  Nephron       Date:  1986       Impact factor: 2.847

6.  Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients.

Authors:  V C Gandhi; H M Humayun; T S Ing; J T Daugirdas; V R Jablokow; S Iwatsuki; W P Geis; J E Hano
Journal:  Arch Intern Med       Date:  1980-09

7.  Five years' experience with continuous ambulatory or continuous cycling peritoneal dialysis in children.

Authors:  T von Lilien; I B Salusky; I Boechat; R B Ettenger; R N Fine
Journal:  J Pediatr       Date:  1987-10       Impact factor: 4.406

8.  Acute changes in peritoneal morphology and transport properties with infectious peritonitis and mechanical injury.

Authors:  C Verger; A Luger; H L Moore; K D Nolph
Journal:  Kidney Int       Date:  1983-06       Impact factor: 10.612

9.  The relationship between peritoneal glucose absorption and body fluid loss by ultrafiltration during continuous ambulatory peritoneal dialysis.

Authors:  R T Krediet; E W Boeschoten; F M Zuyderhoudt; L Arisz
Journal:  Clin Nephrol       Date:  1987-02       Impact factor: 0.975

10.  Long-term changes in transperitoneal water transport during continuous ambulatory peritoneal dialysis.

Authors:  T E Wideröe; L C Smeby; S Mjåland; K Dahl; K J Berg; T Wessel Aas
Journal:  Nephron       Date:  1984       Impact factor: 2.847

View more
  8 in total

Review 1.  Pathogenesis and treatment of peritoneal membrane failure.

Authors:  Ramesh Saxena
Journal:  Pediatr Nephrol       Date:  2007-09-21       Impact factor: 3.714

2.  Risk factors for catheter-related complications in pediatric peritoneal dialysis.

Authors:  Khawla A Rahim; Kristy Seidel; Ruth A McDonald
Journal:  Pediatr Nephrol       Date:  2004-06-17       Impact factor: 3.714

3.  Effect of the peritoneal dialysis prescription on pentosidine in children.

Authors:  Aysun K Bayazit; Beth A Vogt; Katherine M Dell; Ira D Davis; Aytul Noyan; Ali Anarat; Ellis D Avner; Penny Erhard; Miriam F Weiss
Journal:  Pediatr Nephrol       Date:  2003-07-29       Impact factor: 3.714

4.  Longitudinal changes in peritoneal equilibration test with or without peritonitis in children.

Authors:  A Nishi; Y Ito; Y Amamoto; K Aida; H Kato
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

5.  Novel Application of Magnetite Nanoparticle-Mediated Vitamin D3 Delivery for Peritoneal Dialysis-Related Peritoneal Damage.

Authors:  Fong-Yu Cheng; Yuan-Yow Chiou; Shih-Yuan Hung; Tsun-Mei Lin; Hao-Kuang Wang; Chi-Wei Lin; Hung-Hsiang Liou; Min-Yu Chang; Hsi-Hao Wang; Yi-Che Lee
Journal:  Int J Nanomedicine       Date:  2021-03-11

6.  Vitamin D can ameliorate chlorhexidine gluconate-induced peritoneal fibrosis and functional deterioration through the inhibition of epithelial-to-mesenchymal transition of mesothelial cells.

Authors:  Yi-Che Lee; Shih-Yuan Hung; Hung-Hsiang Liou; Tsun-Mei Lin; Chu-Hung Tsai; Sheng-Hsiang Lin; Yau-Sheng Tsai; Min-Yu Chang; Hsi-Hao Wang; Li-Chun Ho; Yi-Ting Chen; Ching-Fang Wu; Ho-Ching Chen; Hsin-Pao Chen; Kuang-Wen Liu; Chih-I Chen; Kuan Min She; Hao-Kuang Wang; Chi-Wei Lin; Yuan-Yow Chiou
Journal:  Biomed Res Int       Date:  2015-10-01       Impact factor: 3.411

7.  1,25(OH)2D3 treatment attenuates high glucose‑induced peritoneal epithelial to mesenchymal transition in mice.

Authors:  Lina Yang; Yi Fan; Xiuli Zhang; Wenyu Huang; Jianfei Ma
Journal:  Mol Med Rep       Date:  2017-07-27       Impact factor: 2.952

8.  The Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage.

Authors:  Yi-Che Lee; Chih-Ting Huang; Fong-Yu Cheng; Shih-Yuan Hung; Tsun-Mei Lin; Yen-Chang Tsai; Chih-I Chen; Hao-Kuang Wang; Chi-Wei Lin; Hung-Hsiang Liou; Min-Yu Chang; Hsi-Hao Wang; Yuan-Yow Chiou
Journal:  Int J Nanomedicine       Date:  2019-12-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.